Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen.

Source:http://linkedlifedata.com/resource/pubmed/id/19450631

Vaccine 2009 Jul 16 27 33 4475-82

Download in:

View as

General Info

PMID
19450631